Derms and Conditions
Derms and Conditions
Dermsquared
Live From Las Vegas! Greatest Hits from Fall Clinical Dermatology 2023
21 minutes Posted Oct 26, 2023 at 10:00 am.
0:00
21:17
Download MP3
Show notes

In this episode of Derms and Conditions, Dr. Jim Del Rosso and Dr. Gary Goldenberg discuss some of the highlights from the meeting. These include recent FDA approvals such as

bimekizumab for psoriasis and the triple topical combination for acne vulgaris, the newer  nonsteroidal topical agents, tapinarof and roflumilast, and their relevant clinical use, the 

significance of narrow-spectrum oral antibiotic therapy with sarecycline as compared to  other oral tetracycline with regard to antibiotic resistance, and physical devices such as

laser systems used to treat acne vulgaris.